INGN
Inogen, Inc. NASDAQ Listed Feb 14, 2014$7.19
After hrs
$7.02
+0.00%
Mkt Cap $196.5M
52w Low $5.34
48.8% of range
52w High $9.13
50d MA $6.51
200d MA $7.04
P/E (TTM)
-8.2x
EV/EBITDA
-35.4x
P/B
1.0x
Debt/Equity
0.1x
ROE
-11.8%
P/FCF
-8.5x
RSI (14)
—
ATR (14)
—
Beta
1.71
50d MA
$6.51
200d MA
$7.04
Avg Volume
301.9K
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
301 Coromar Drive · Goleta, CA 93117 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.24 | -0.30 | -25.0% | 7.19 | -0.3% | -2.4% | — | — | — | — | — |
| Feb 24, 2026 | AMC | -0.36 | -0.26 | +27.8% | 5.84 | -6.3% | +2.9% | +10.3% | +4.5% | +5.8% | +6.3% | — |
| Nov 5, 2025 | AMC | -0.22 | -0.20 | +9.1% | 7.39 | -0.8% | -4.9% | -5.4% | -5.0% | -5.4% | -4.1% | — |
| Aug 7, 2025 | AMC | -0.22 | -0.15 | +31.8% | 5.87 | +2.2% | +10.4% | +19.9% | +29.1% | +31.2% | +30.7% | — |
| May 7, 2025 | AMC | -0.52 | -0.25 | +51.9% | 7.17 | +0.7% | -11.4% | -13.0% | -12.1% | -14.4% | -18.0% | — |
| Feb 25, 2025 | AMC | -0.56 | -0.41 | +26.8% | 9.52 | +25.4% | -14.8% | -16.5% | -12.5% | -14.6% | -15.7% | — |
| Nov 7, 2024 | AMC | -0.49 | -0.25 | +49.0% | 9.46 | +13.6% | +17.2% | +16.5% | +10.4% | +9.2% | +5.2% | — |
| Aug 6, 2024 | AMC | -0.55 | -0.24 | +56.4% | 8.15 | +21.5% | +36.0% | +43.2% | +51.2% | +44.7% | +53.3% | — |
| May 7, 2024 | AMC | -0.76 | -0.62 | +18.4% | 7.30 | +12.3% | +12.9% | +19.0% | +15.9% | +20.8% | +22.2% | — |
| Feb 27, 2024 | AMC | -0.62 | -1.14 | -83.9% | 9.34 | -24.0% | -32.7% | -28.8% | -24.7% | -28.5% | -27.7% | — |
| Nov 7, 2023 | AMC | -0.57 | -1.97 | -245.6% | 5.27 | -5.9% | -1.1% | -8.7% | -8.0% | -7.8% | +4.2% | — |
| Aug 7, 2023 | AMC | -0.59 | -0.42 | +28.8% | 7.50 | -19.7% | -13.6% | -17.1% | -18.5% | -17.7% | -18.0% | — |
| May 4, 2023 | AMC | -0.77 | -0.63 | +18.2% | 13.75 | +0.4% | -5.4% | -13.8% | -18.7% | -19.3% | -19.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 22 | Needham | Upgrade | Hold → Buy | — | $5.96 | $6.54 | +9.7% | +13.3% | +9.6% | +11.1% | +9.6% | +9.6% |
| May 8 | Stifel | Maintains | Hold → Hold | — | $7.17 | $7.22 | +0.7% | -11.4% | -13.0% | -12.1% | -14.4% | -18.0% |
| Apr 9 | Needham | Maintains | Hold → Hold | — | $6.59 | $6.48 | -1.7% | +6.8% | +7.4% | +10.9% | +11.1% | +9.3% |
| Feb 27 | Needham | Maintains | Hold → Hold | — | $8.11 | $8.02 | -1.1% | -2.0% | +2.7% | +0.2% | -1.0% | +2.0% |
| Feb 26 | Needham | Maintains | Hold → Hold | — | $9.52 | $11.94 | +25.4% | -14.8% | -16.5% | -12.5% | -14.6% | -15.7% |
| Jan 30 | Needham | Maintains | Hold → Hold | — | $12.53 | $12.72 | +1.5% | -4.6% | -6.7% | -8.5% | -4.5% | -5.4% |
| Jan 14 | Needham | Maintains | Hold → Hold | — | $10.33 | $11.44 | +10.7% | +2.8% | +5.3% | +1.8% | +1.4% | +8.3% |
| May 8 | Stifel | Maintains | Hold → Hold | — | $7.30 | $8.20 | +12.3% | +12.9% | +19.0% | +15.9% | +20.8% | +22.2% |
| Feb 15 | William Blair | Upgrade | Market Perform → Outperform | — | $8.51 | $9.16 | +7.6% | +19.3% | +17.9% | +11.5% | +10.3% | +10.1% |
| Nov 8 | JP Morgan | Maintains | Underweight → Underweight | — | $5.27 | $4.96 | -5.9% | -1.1% | -8.7% | -8.0% | -7.8% | +4.2% |
| Aug 8 | JP Morgan | Downgrade | Neutral → Underweight | — | $7.50 | $6.02 | -19.7% | -13.6% | -17.1% | -18.5% | -17.7% | -18.0% |
| Aug 8 | Stifel | Maintains | Hold → Hold | — | $7.50 | $6.02 | -19.7% | -13.6% | -17.1% | -18.5% | -17.7% | -18.0% |
| Jul 14 | Needham | Downgrade | Buy → Hold | — | $10.26 | $9.62 | -6.2% | -13.4% | -11.2% | -15.6% | -18.1% | -15.8% |
| Apr 20 | Needham | Maintains | Buy → Buy | — | $13.00 | $12.97 | -0.2% | +2.2% | +3.1% | +5.7% | +1.6% | +0.3% |
| Feb 28 | Needham | Maintains | Buy → Buy | — | $16.50 | $16.20 | -1.8% | -5.0% | -5.7% | -4.8% | -6.2% | -10.2% |
| Feb 24 | Needham | Maintains | Buy → Buy | — | $23.16 | $20.35 | -12.1% | -31.4% | -28.8% | -32.3% | -32.8% | -32.2% |
| Jan 17 | William Blair | Downgrade | Outperform → Market Perform | — | $23.28 | $22.45 | -3.6% | -2.9% | -5.5% | -6.7% | -2.9% | +3.4% |
| Nov 3 | JP Morgan | Maintains | Neutral → Neutral | — | $21.36 | $20.87 | -2.3% | -5.1% | -3.1% | -2.3% | -2.7% | -5.5% |
| Nov 2 | Needham | Maintains | Buy → Buy | — | $23.18 | $21.96 | -5.3% | -7.9% | -12.5% | -10.7% | -10.0% | -10.3% |
| May 9 | Stifel | Maintains | Hold → Hold | — | $24.94 | $24.22 | -2.9% | -5.6% | -5.8% | -8.3% | -2.9% | +1.4% |
| May 6 | Needham | Maintains | Buy → Buy | — | $24.09 | $24.11 | +0.1% | +3.5% | -2.3% | -2.4% | -5.0% | +0.5% |
| Dec 9 | Needham | Upgrade | Hold → Buy | — | $33.08 | $34.63 | +4.7% | +4.4% | +4.2% | +0.5% | -1.6% | -0.2% |
| Nov 8 | Stifel | Maintains | Hold → Hold | — | $36.92 | $37.07 | +0.4% | +1.4% | -1.4% | -1.5% | -5.7% | -8.2% |
| Nov 5 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $38.88 | $40.49 | +4.1% | -5.0% | -3.8% | -6.4% | -6.4% | -10.5% |
| Nov 2 | JP Morgan | Upgrade | Underweight → Neutral | — | $39.66 | $40.03 | +0.9% | -3.2% | -1.0% | -2.0% | -6.9% | -5.6% |
| Aug 5 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $82.26 | $65.39 | -20.5% | -26.7% | -21.9% | -20.9% | -21.5% | -23.9% |
| Jun 4 | William Blair | Upgrade | Market Perform → Outperform | — | $59.49 | $62.25 | +4.6% | +7.1% | +5.5% | +6.3% | +4.8% | +5.0% |
| May 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $67.09 | $69.00 | +2.8% | -1.9% | -1.6% | -0.7% | -2.6% | -0.5% |
| May 5 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $67.09 | $69.00 | +2.8% | -1.9% | -1.6% | -0.7% | -2.6% | -0.5% |
| Feb 25 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $51.59 | $53.91 | +4.5% | +2.3% | +1.7% | +3.0% | -4.1% | -6.3% |
| Dec 14 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $38.46 | $42.76 | +11.2% | +7.5% | +6.8% | +6.5% | +6.8% | +6.0% |
| Dec 14 | KeyBanc | Upgrade | Sector Weight → Overweight | — | $38.46 | $42.76 | +11.2% | +7.5% | +6.8% | +6.5% | +6.8% | +6.0% |
| Aug 5 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $30.64 | $31.98 | +4.4% | +13.3% | +11.7% | +13.9% | +5.9% | +4.4% |
| Jul 23 | Needham | Downgrade | Buy → Hold | — | $34.97 | $33.34 | -4.7% | -5.7% | -8.8% | -11.4% | -14.3% | -10.5% |
| Jun 11 | William Blair | Downgrade | Outperform → Market Perform | — | $37.39 | $35.50 | -5.1% | -10.9% | -12.1% | -8.0% | -8.8% | -8.9% |
| Jun 1 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $38.00 | $37.24 | -2.0% | +1.4% | +2.2% | +1.0% | +0.3% | +8.5% |
| May 6 | Needham | Maintains | Buy → Buy | — | $52.90 | $48.58 | -8.2% | -25.3% | -22.1% | -24.1% | -25.1% | -30.0% |
| May 6 | SVB Leerink | Maintains | Market Perform → Market Perform | — | $52.90 | $48.58 | -8.2% | -25.3% | -22.1% | -24.1% | -25.1% | -30.0% |
| Feb 26 | JP Morgan | Maintains | Underweight → Underweight | — | $41.98 | $37.25 | -11.3% | +14.1% | +14.2% | +9.1% | +13.6% | +5.1% |
| Dec 20 | JP Morgan | Maintains | Underweight → Underweight | — | $71.07 | $71.52 | +0.6% | -0.1% | -0.3% | +0.6% | -1.1% | -3.6% |
| Nov 6 | Needham | Upgrade | Hold → Buy | — | $59.32 | $68.63 | +15.7% | +14.1% | +16.4% | +16.4% | +14.0% | +16.4% |
| Aug 8 | Stifel Nicolaus | Downgrade | Buy → Hold | — | $42.32 | $41.98 | -0.8% | +10.3% | +6.2% | +6.3% | +8.6% | +1.4% |
| Aug 8 | SVB Leerink | Downgrade | Outperform → Market Perform | — | $42.32 | $41.98 | -0.8% | +10.3% | +6.2% | +6.3% | +8.6% | +1.4% |
| Aug 8 | Stifel | Downgrade | Buy → Hold | — | $42.32 | $41.98 | -0.8% | +10.3% | +6.2% | +6.3% | +8.6% | +1.4% |
| Jul 3 | JP Morgan | Downgrade | Neutral → Underweight | — | $65.26 | $63.46 | -2.8% | +0.2% | +1.0% | -2.4% | -3.1% | -2.4% |
| Jun 28 | Needham | Downgrade | Strong Buy → Buy | — | $65.49 | $63.53 | -3.0% | +1.9% | +1.9% | -0.4% | -0.2% | +0.6% |
| May 8 | Stifel Nicolaus | Maintains | Buy → Buy | — | $91.14 | $64.62 | -29.1% | -25.6% | -20.7% | -18.8% | -19.7% | -19.5% |
| May 8 | JP Morgan | Downgrade | Overweight → Neutral | — | $91.14 | $64.62 | -29.1% | -25.6% | -20.7% | -18.8% | -19.7% | -19.5% |
| May 8 | Stifel | Maintains | Buy → Buy | — | $91.14 | $64.62 | -29.1% | -25.6% | -20.7% | -18.8% | -19.7% | -19.5% |
| Nov 20 | Needham | Upgrade | Buy → Strong Buy | — | $137.45 | $138.43 | +0.7% | +3.0% | +0.5% | +1.0% | +3.2% | +3.6% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Vafa Jamali's appointment as director signals potential strategic shifts in governance and decision-making, warranting investor attention to board composition changes affecting corporate direction and oversight quality.
Apr 6
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
A new executive at Baxter or Inogen with a $525,000 base salary and 70% bonus potential signals leadership continuity, but investors should monitor whether this hire strengthens operational execution or represents reactive replacement.
Mar 30
8-K · 7.01
! Medium
Inogen Inc -- 8-K 7.01: Regulation FD Disclosure
Inogen's board authorized a $30 million share repurchase program, signaling management confidence in the company's valuation and demonstrating commitment to returning capital to shareholders.
Feb 24
Data updated apr 25, 2026 3:36pm
· Source: massive.com